In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...